A detailed history of Smartleaf Asset Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 189 shares of BNTX stock, worth $21,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares
189
Previous 117 61.54%
Holding current value
$21,381
Previous $9.4 Million 137.59%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$78.36 - $124.66 $5,641 - $8,975
72 Added 61.54%
189 $22.3 Million
Q2 2024

Aug 13, 2024

BUY
$80.36 - $102.87 $8,196 - $10,492
102 Added 680.0%
117 $9.4 Million
Q1 2024

Oct 07, 2024

SELL
$88.96 - $112.35 $9,073 - $11,459
-102 Reduced 87.18%
15 $1.39 Million
Q1 2024

May 02, 2024

BUY
$88.96 - $112.35 $1,334 - $1,685
15 New
15 $1.59 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.